Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination.

Passarin MG, Moretto G, Musso AM, Ottaviani S, Masotto B, Ghimenton C, Iuzzolino P, Buffone E, Rudà R, Soffietti R, Vattemi E, Pedersini R.

J Neurooncol. 2010 May;97(3):439-44. doi: 10.1007/s11060-009-0040-0. Epub 2009 Oct 31.

PMID:
19876600
3.

Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.

Schaefer N, Rasch K, Moehlenbruch M, Urbach H, Stuplich M, Blasius E, Scheffler B, Herrlinger U, Glas M.

Acta Oncol. 2011 Nov;50(8):1260-2. doi: 10.3109/0284186X.2011.586001. Epub 2011 Jul 8. No abstract available.

PMID:
21736503
4.

Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: report of a unique case successfully treated with Temozolomide.

Michotte A, Chaskis C, Sadones J, Veld PI, Neyns B.

J Neurol Sci. 2009 Dec 15;287(1-2):267-70. doi: 10.1016/j.jns.2009.08.047. Epub 2009 Sep 13.

PMID:
19751941
5.

Intrathecal liposomal cytarabine and leptomeningeal medulloblastoma relapse: a valuable therapeutic option.

Mastronuzzi A, Del Bufalo F, Iacono A, Secco DE, Serra A, Colafati GS, DE Ioris MA, Corsetti T.

Anticancer Res. 2013 Aug;33(8):3515-8.

PMID:
23898128
6.

Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child.

Lassaletta A, Perez-Olleros P, Scaglione C, Sirvent S, De Prada I, Perez-Martinez A, Ruiz-Hernandez A, Madero L.

J Neurooncol. 2007 Jul;83(3):303-6. Epub 2007 Jan 24.

PMID:
17245619
7.

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.

Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S, Sardell S, Traish D, Gonsalves A, Wilkins P, Westbury C.

Ann Oncol. 2003 Dec;14(12):1715-21.

PMID:
14630674
8.

Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.

Niwińska A, Rudnicka H, Murawska M.

Clin Breast Cancer. 2015 Feb;15(1):66-72. doi: 10.1016/j.clbc.2014.07.004. Epub 2014 Aug 22.

PMID:
25287959
9.

Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement.

Navajas A, Lassaletta A, Morales A, López-Ibor B, Sábado C, Moscardó C, Mateos E, Molina J, Sagaseta M, Sastre A.

Clin Transl Oncol. 2012 Apr;14(4):280-6. doi: 10.1007/s12094-012-0796-0.

PMID:
22484635
10.

Temozolomide chemotherapy in recurrent oligodendroglioma.

van den Bent MJ, Keime-Guibert F, Brandes AA, Taphoorn MJ, Kros JM, Eskens FA, Carpentier AF.

Neurology. 2001 Jul 24;57(2):340-2.

PMID:
11468326
11.

Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report.

Salmaggi A, Silvani A, Eoli M, Lamperti E, Boiardi A.

Neurol Sci. 2002 Dec;23(5):257-8. No abstract available.

PMID:
12528690
12.

Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma.

Edwards MS, Levin VA, Seager ML, Wilson CB.

Childs Brain. 1981;8(6):444-51.

PMID:
6796342
13.

Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.

Guillaume DJ, Doolittle ND, Gahramanov S, Hedrick NA, Delashaw JB, Neuwelt EA.

Neurosurgery. 2010 Jan;66(1):48-58; discussion 58. doi: 10.1227/01. NEU.0000363152.37594. F7.

14.
15.

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas.

Triebels VH, Taphoorn MJ, Brandes AA, Menten J, Frenay M, Tosoni A, Kros JM, Stege EB, Enting RH, Allgeier A, van Heuvel I, van den Bent MJ.

Neurology. 2004 Sep 14;63(5):904-6.

PMID:
15365146
16.

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B.

Ann Oncol. 2003 Apr;14(4):599-602.

PMID:
12649108
17.

Spinal cord pilocytic astrocytoma with leptomeningeal dissemination to the brain. Case report and review of the literature.

Abel TJ, Chowdhary A, Thapa M, Rutledge JC, Geyer JR, Ojemann J, Avellino AM.

J Neurosurg. 2006 Dec;105(6 Suppl):508-14. Review.

PMID:
17184088
18.

Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131.

Vogelbaum MA, Berkey B, Peereboom D, Macdonald D, Giannini C, Suh JH, Jenkins R, Herman J, Brown P, Blumenthal DT, Biggs C, Schultz C, Mehta M.

Neuro Oncol. 2009 Apr;11(2):167-75. doi: 10.1215/15228517-2008-073. Epub 2008 Sep 8.

19.

Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy.

Falchi L, Gunnellini M, Franco L, Ferrazza P, Ascani S, Liberati AM.

J Neurooncol. 2010 Mar;97(1):53-7. doi: 10.1007/s11060-009-9985-2. Epub 2009 Aug 21.

PMID:
19696967
20.

Efficacy of temozolomide treatment in patients with high-grade glioma.

Oshiro S, Tsugu H, Komatsu F, Ohmura T, Ohta M, Sakamoto S, Fukushima T, Inoue T.

Anticancer Res. 2009 Mar;29(3):911-7.

Supplemental Content

Support Center